139 related articles for article (PubMed ID: 16119436)
1. A 9 year prospective cohort study of endoscoped patients with upper gastrointestinal symptoms.
Westbrook JI; Duggan AE; Duggan JM; Westbrook MT
Eur J Epidemiol; 2005; 20(7):619-27. PubMed ID: 16119436
[TBL] [Abstract][Full Text] [Related]
2. Short-term treatment of gastroesophageal reflux disease.
van Pinxteren B; Numans ME; Lau J; de Wit NJ; Hungin AP; Bonis PA
J Gen Intern Med; 2003 Sep; 18(9):755-63. PubMed ID: 12950485
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of the long-term outcome in reflux esophagitis in a low-prevalence gastroesophageal reflux disease region.
Chang CS; Yang SS; Ko CW; Lien HC; Yeh HZ; Chen GH
Scand J Gastroenterol; 2003 Nov; 38(11):1131-5. PubMed ID: 14686715
[TBL] [Abstract][Full Text] [Related]
4. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
[TBL] [Abstract][Full Text] [Related]
5. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
Chan J; Hui RL; Szpakowski JL
Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
[TBL] [Abstract][Full Text] [Related]
6. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
7. The long-term natural history of gastroesophageal reflux disease.
Sontag SJ; Sonnenberg A; Schnell TG; Leya J; Metz A
J Clin Gastroenterol; 2006; 40(5):398-404. PubMed ID: 16721220
[TBL] [Abstract][Full Text] [Related]
8. Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors.
Smith T; Verzola E; Mertz H
Gastrointest Endosc; 2003 Jul; 58(1):9-13. PubMed ID: 12838213
[TBL] [Abstract][Full Text] [Related]
9. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
Armstrong D; Veldhuyzen SJ; Chung SA; Shapiro CM; Dhillon S; Escobedo S; Chakraborty BK; Mann V; Tanser L; Nevin K
Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors and acute interstitial nephritis.
Geevasinga N; Coleman PL; Webster AC; Roger SD
Clin Gastroenterol Hepatol; 2006 May; 4(5):597-604. PubMed ID: 16630752
[TBL] [Abstract][Full Text] [Related]
11. [Acid-related disease in the population of two Norwegian municipalities--diagnosis and drug therapy].
Vetvik K; Straand J
Tidsskr Nor Laegeforen; 2001 Feb; 121(5):557-62. PubMed ID: 11301609
[TBL] [Abstract][Full Text] [Related]
12. Nissen fundoplication
Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
[TBL] [Abstract][Full Text] [Related]
13. How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
Galmiche JP
Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S3-6. PubMed ID: 10929891
[TBL] [Abstract][Full Text] [Related]
14. Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy.
Rackoff A; Agrawal A; Hila A; Mainie I; Tutuian R; Castell DO
Dis Esophagus; 2005; 18(6):370-3. PubMed ID: 16336606
[TBL] [Abstract][Full Text] [Related]
15. The Effect of H
Shim YK; Kim N
Korean J Gastroenterol; 2017 Jul; 70(1):4-12. PubMed ID: 28728310
[TBL] [Abstract][Full Text] [Related]
16. Differences in the diagnostic yield of upper gastrointestinal endoscopy in dyspeptic patients receiving proton-pump inhibitors and H2-receptor antagonists.
Mitchell RM; Collins JS; Watson RG; Tham TC
Endoscopy; 2002 Jul; 34(7):524-6. PubMed ID: 12170401
[TBL] [Abstract][Full Text] [Related]
17. Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure.
Strid H; Fjell A; Simrén M; Björnsson ES
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):137-42. PubMed ID: 19212202
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Tolerability of Different Recommended Doses of PPIs and H
Zhang C; Kwong JS; Yuan RX; Chen H; Xu C; Wang YP; Yang GL; Yan JZ; Peng L; Zeng XT; Weng H; Luo J; Niu YM
Sci Rep; 2017 Jan; 7():41021. PubMed ID: 28102361
[TBL] [Abstract][Full Text] [Related]
19. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
